Organogenesis Holdings (ORGO) Financial Statements & Analysis

Organogenesis Holdings (ORGO) Income Statement

Organogenesis Holdings reported revenue of $563.03M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 16.8% from $482.04M a year earlier. Net income was $37.03M, a net margin of 6.6%. Gross margin was 75.6% and operating margin 9.9%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $43.76M, down 56.7% from the same quarter a year earlier.

Organogenesis Holdings Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Organogenesis Holdings Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	563.03	482.04	433.14	450.89	467.36	338.30	260.98	193.45	0.00
Cost of Revenue	137.52	115.74	106.48	105.02	114.20	87.32	75.95	68.81	4.59
Gross Profit	425.51	366.30	326.66	345.87	353.16	250.98	185.03	124.64	-4.59
Operating Expenses
Research & Development	44.54	50.27	44.38	39.76	30.74	20.09	14.80	10.74	0.00
Selling, General & Administrative	326.24	294.51	269.75	283.81	250.20	203.37	200.09	161.96	4.59
Operating Expenses	369.64	367.59	314.13	323.57	280.94	223.46	214.89	172.70	4.59
Operating Income	55.87	-1.28	12.53	22.30	72.22	27.52	-29.85	-51.56	-4.59
Other Income/Expense
Interest Income	2.28	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.00
Interest Expense	0.00	-1.54	2.19	2.01	7.24	-11.28	9.00	10.85	8.01
Other Income/Expense	-11.18	-1.52	0.06	-2.02	-1.90	0.10	-8.71	-13.19	3.40
Income
Income Before Tax	46.97	-2.81	10.39	20.28	63.09	17.76	-38.56	-64.75	-2.09
Income Tax Expense	9.94	-3.67	5.45	4.75	-31.12	0.53	0.15	0.08	-0.05
Net Income	37.03	-0.94	4.95	15.53	94.20	17.23	-38.71	-64.83	-2.09
Net Income - Continuous Operations	37.03	0.86	4.95	15.53	94.20	17.23	-38.71	-64.83	-2.09
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	82.81	38.54	36.03	40.32	87.00	35.70	-19.74	-46.92	-2.09
EBIT	55.87	21.52	12.58	24.57	70.32	27.52	-	-	-
Depreciation & Amortization	26.94	17.03	23.45	18.03	16.68	8.18	9.83	6.98	5.63
Earnings Per Share
Basic EPS	-	-	-	-	1.00	-	-	-1.00	-
Diluted EPS	-	-	-	-	1.00	-	-	-1.00	-
Basic Shares Outstanding	126.74	131.67	131.23	130.07	128.33	107.74	92.84	68.97	63.88
Diluted Shares Outstanding	130.25	131.67	132.75	132.38	133.66	111.36	92.84	69.32	63.88

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Organogenesis Holdings Financial Statements

What was Organogenesis Holdings's revenue in fiscal 2025?

Organogenesis Holdings reported revenue of $563.03M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 16.8% from $482.04M a year earlier.

Is Organogenesis Holdings profitable?

Yes. Organogenesis Holdings earned net income of $37.03M in fiscal 2025, a net margin of 6.6%. In fiscal 2024 it lost $937.00K.

What is Organogenesis Holdings's operating margin?

Organogenesis Holdings's operating income was $55.87M on revenue of $563.03M in fiscal 2025, an operating margin of 9.9%, compared with -0.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition